Crystallization in industry and biomedicine

 
Thursday, July 7

chair: Bernhard Rupp 

 11:00 Allan D’Arcy
Actelion Pharmaceuticals, Switzerland
A rational approach to crystallising proteins in the pharmaceutical industry, the impact of micro seed matrix seeding htm pdf
11:30 Jan Kubíček
Cube Biotech
Expression and purification of membrane proteins in context of functionality htm pdf
11:50 Linda Oster Landgren
Astra Zeneca, Gothenburg, Sweden
Successful generation of structural information for fragment-based drug discovery  htm pdf
12:10 Thomas Peignier 
Space Applications Services, Zaventem, Belgium
XRayLab: an X-ray diffraction facility for the International Space Station dedicated to the study of space-grown crystals  htm pdf